Progentec Diagnostics Announces Launch of Novel Test That Anticipates Onset of Lupus-Related Flares

The aiSLE™ DX Flare Risk Index uses a set of blood-based biomarkers that are measurably altered before the onset of flare symptoms in patients with systemic lupus erythematosus.